| Source publication date | |
|---|---|
| Reported on Testosterone Science | |
| Outlet type | Medical and professional news |
| Population | Men |
| Source | News-Medical |
| URL | news-medical.net/news/20260614/Testosterone-benefits-older-men-with-T2D-risk-when-combined-with-lifestyle-changes.aspx (opens in a new tab) |
Specific Claim Evaluated
In a 4-year extension of the T4DM trial, testosterone maintained improvements in body composition and sexual desire, blood glucose benefits diminished after 2 years, and the benefits require engagement in a lifestyle program.
Primary Research Supporting or Contradicting the Claim
In T4DM, 1,007 men aged 50 to 74 years with impaired glucose tolerance or newly diagnosed type 2 diabetes and low-normal testosterone, all enrolled in a lifestyle program, testosterone for 2 years reduced the proportion with type 2 diabetes compared with placebo (Wittert et al., 2021).
Corrected Evidence-Based Interpretation
The extension followed 121 of 1,007 men who chose to continue blinded treatment without the lifestyle program. Because the original trial had no testosterone-alone arm, it did not test whether benefit requires a lifestyle program.
Rationale for Grade
The report is consistent with the conference presentation, but it gives no effect sizes, does not state that the extension included a small self-selected subgroup and repeats the claim that benefit depends on lifestyle engagement without noting that the trial design could not test this. These omissions change how a reader would weigh the findings.
References
- Wittert G, Bracken K, Robledo KP, Grossmann M, Yeap BB, Handelsman DJ, Stuckey B, Conway A, Inder W, McLachlan R, et al. Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial. Lancet Diabetes Endocrinol. 2021;9(1):32-45. PMID
Supporting excerpt: "reduced the proportion of participants with type 2 diabetes"